Showing results (1-10 of 438) with videos related to
Sort By:
Pageof 44
Pharmacological Research|June 29, 2011
On the path from chemistry to neuroscience: early explorations in chemical medicine under the mentorship of Dr. Erminio Costa, a neuroscientist with a big brain and a bigger heartAlan P KozikowskiJournal of Chemical Information and Modeling|February 3, 2009
Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validationHao Tang, Xiang S Wang, Xi-Ping Huang, et al.Molecular Informatics|July 28, 2016
Best Practices for QSAR Model Development, Validation, and ExploitationAlexander TropshaExpert Opinion on Therapeutic Patents|December 24, 2019
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)Sida Shen, Alan P KozikowskiExperientia Supplementum (2012)|September 5, 2012
Recent trends in statistical QSAR modeling of environmental chemical toxicityAlexander TropshaChemmedchem|November 26, 2015
Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?Sida Shen, Alan P KozikowskiChemmedchem|October 29, 2015
We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS DisordersJianjun Cheng, Alan P KozikowskiJournal of Medicinal Chemistry|October 6, 2025
How a Medicinal Chemistry Project Changed the Way Prostate Cancer is Diagnosed and TreatedAlan P Kozikowski, Joseph NealeThe Journal of Organic Chemistry|September 19, 2019
Diastereofacial Selection in Nitrile Oxide Cycloaddition Reactions. The Anti-Directing Effect of an Allylic Oxygen and Some New Results on the Ring Metalation of Isoxazolines. A Synthesis of (±)-BlastmycinoneAlan P Kozikowski, Arun K GhoshCurrent Pharmaceutical Design|March 14, 2008
Chemical origins of isoform selectivity in histone deacetylase inhibitorsKyle V Butler, Alan P KozikowskiPageof 44